Avantax Advisory Services’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-922	Closed	-$238K	–	1210
2021 Q2	$238K	Sell	922 -17	-2%	-$4.39K	﹤0.01%	999
2021 Q1	$282K	Buy	+939	New	+$282K	0.01%	831
2020 Q4	–	Sell	-1,504	Closed	-$372K	–	1209
2020 Q3	$372K	Buy	+1,504	New	+$372K	0.01%	925